ADMA 株価分析 — ADMA BIOLOGICS INC (Healthcare >> Biotechnology)
ADMA に関するよくある質問
ADMAのPER(株価収益率)は?
ADMA BIOLOGICS INC(ADMA)は現在PER 12.15倍で取引されています。
ADMAのROE(自己資本利益率)は?
ADMA BIOLOGICS INCのROEは42.36%です。
ADMAの配当利回りは?
ADMA BIOLOGICS INCの配当利回りは0.00%です。
ADMAの品質スコア(Quality Score)は?
当社のAIはADMAの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ADMAは今が買い時ですか?
当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ADMAはどのセクターに属しますか?
ADMA BIOLOGICS INCはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)
ADMA AI Analysis Summary
Our AI summary for ADMA: ADMA BIOLOGICS INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 12.15, ROE of 42.36%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 8.46
Price
-0.21
(-2.42%)
Day Change
|
|
|---|
ADMA, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Deepscope 分析 |
|
52% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 82 |
| Magic Formula Rank by ROA |
241
|
| Magic Formula Rank by ROE |
241
|
| Magic Formula Rank by ROIC |
227
|
| Price | 8.46 |
| PBV / Sector |
5.15 / 5.20
|
| Earning Per Share | 0.70 |
| PE / Sector |
12.15 / 19.97
GOOD
|
| PEG or PE/Growth / Sector |
-0.04 / 1.22
|
| Average 1M Daily Value |
21.23 M
GREAT
|
| Average 1W Daily Value |
16.05 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
72% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:26 |
| Symbol | ADMA |
| Name | ADMA BIOLOGICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 231.77 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2,009.47 / 9,903.94 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 465 State Route 17, Ramsey, NJ, United States, 07446
Phone: 201 478 5552
Website: https://www.admabiologics.com
Employees: 640
Sector: Healthcare >> Biotechnology
Description: ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google